Back to Search Start Over

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.

Authors :
Bogetofte, Helle
Ryan, Brent J.
Jensen, Pia
Schmidt, Sissel I.
Vergoossen, Dana L.E.
Barnkob, Mike B.
Kiani, Lisa N.
Chughtai, Uroosa
Heon-Roberts, Rachel
Caiazza, Maria Claudia
McGuinness, William
Márquez-Gómez, Ricardo
Vowles, Jane
Bunn, Fiona S.
Brandes, Janine
Kilfeather, Peter
Connor, Jack P.
Fernandes, Hugo J.R.
Caffrey, Tara M.
Meyer, Morten
Source :
Cell Reports; Mar2023, Vol. 42 Issue 3, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Variants at the GBA locus, encoding glucocerebrosidase, are the strongest common genetic risk factor for Parkinson's disease (PD). To understand GBA -related disease mechanisms, we use a multi-part-enrichment proteomics and post-translational modification (PTM) workflow, identifying large numbers of dysregulated proteins and PTMs in heterozygous GBA - N370S PD patient induced pluripotent stem cell (iPSC) dopamine neurons. Alterations in glycosylation status show disturbances in the autophagy-lysosomal pathway, which concur with upstream perturbations in mammalian target of rapamycin (mTOR) activation in GBA -PD neurons. Several native and modified proteins encoded by PD-associated genes are dysregulated in GBA -PD neurons. Integrated pathway analysis reveals impaired neuritogenesis in GBA -PD neurons and identify tau as a key pathway mediator. Functional assays confirm neurite outgrowth deficits and identify impaired mitochondrial movement in GBA -PD neurons. Furthermore, pharmacological rescue of glucocerebrosidase activity in GBA -PD neurons improves the neurite outgrowth deficit. Overall, this study demonstrates the potential of PTMomics to elucidate neurodegeneration-associated pathways and potential drug targets in complex disease models. [Display omitted] • Proteomic/PTMomic analysis of GBA patient iPSC neurons identify disease phenotypes • PTM changes are highly abundant on lysosomal proteins and PD GWAS-related proteins • mTOR activation and mitochondrial movement perturbations are identified • GBA patient neurons show neuritogenesis defects that are rescued by a GCase chaperone Bogetofte et al. apply a post-translational proteomics pipeline to iPSC-dopaminergic neurons from patients with Parkinson's with a GBA-N370S mutation. This workflow simultaneously quantifies changes in protein phosphorylation, sialylation, and cysteine modifications, identifying affected pathways and phenotypes including impaired neurite outgrowth in GBA-N370S patient dopaminergic neurons that can be rescued by a GBA chaperone. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
26391856
Volume :
42
Issue :
3
Database :
Complementary Index
Journal :
Cell Reports
Publication Type :
Academic Journal
Accession number :
162680908
Full Text :
https://doi.org/10.1016/j.celrep.2023.112180